 Katja Gist
Concepts (295)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Kidney Injury | 86 | 2025 | 790 | 19.660 |
Why?
| | Cardiac Surgical Procedures | 25 | 2024 | 499 | 7.640 |
Why?
| | Water-Electrolyte Imbalance | 14 | 2024 | 42 | 4.680 |
Why?
| | Creatinine | 18 | 2024 | 491 | 3.720 |
Why?
| | Postoperative Complications | 22 | 2024 | 2483 | 3.580 |
Why?
| | Critical Illness | 22 | 2025 | 758 | 3.390 |
Why?
| | Heart Defects, Congenital | 10 | 2025 | 758 | 2.660 |
Why?
| | Milrinone | 5 | 2021 | 29 | 2.420 |
Why?
| | Extracorporeal Membrane Oxygenation | 7 | 2024 | 282 | 2.410 |
Why?
| | Lipocalin-2 | 5 | 2024 | 75 | 2.090 |
Why?
| | Cardiopulmonary Bypass | 7 | 2024 | 202 | 2.060 |
Why?
| | Biomarkers | 19 | 2024 | 3973 | 2.020 |
Why?
| | Renal Replacement Therapy | 13 | 2024 | 87 | 1.970 |
Why?
| | Norwood Procedures | 4 | 2024 | 29 | 1.930 |
Why?
| | Peritoneal Dialysis | 3 | 2020 | 95 | 1.790 |
Why?
| | Infant, Newborn | 47 | 2025 | 5762 | 1.770 |
Why?
| | Child | 66 | 2025 | 20883 | 1.760 |
Why?
| | Chlorides | 3 | 2020 | 139 | 1.740 |
Why?
| | Retrospective Studies | 60 | 2025 | 14518 | 1.620 |
Why?
| | Kidney | 15 | 2024 | 1385 | 1.450 |
Why?
| | Arterial Switch Operation | 2 | 2020 | 9 | 1.390 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2018 | 117 | 1.340 |
Why?
| | Furosemide | 3 | 2024 | 39 | 1.290 |
Why?
| | Infant | 35 | 2025 | 9024 | 1.280 |
Why?
| | Humans | 119 | 2025 | 129650 | 1.250 |
Why?
| | Risk Factors | 34 | 2025 | 9765 | 1.230 |
Why?
| | Prospective Studies | 21 | 2024 | 7133 | 1.190 |
Why?
| | Intensive Care Units, Pediatric | 11 | 2025 | 203 | 1.160 |
Why?
| | Heart Diseases | 3 | 2025 | 350 | 1.140 |
Why?
| | Hospital Mortality | 13 | 2024 | 850 | 1.120 |
Why?
| | Water-Electrolyte Balance | 7 | 2025 | 34 | 1.110 |
Why?
| | Child, Preschool | 30 | 2025 | 10517 | 1.090 |
Why?
| | Male | 65 | 2025 | 63681 | 1.040 |
Why?
| | Hypoxia-Ischemia, Brain | 2 | 2024 | 34 | 1.030 |
Why?
| | Sepsis | 3 | 2024 | 574 | 0.960 |
Why?
| | Heart Failure | 5 | 2023 | 2150 | 0.950 |
Why?
| | Female | 62 | 2025 | 68776 | 0.940 |
Why?
| | Chemokines, CC | 1 | 2024 | 33 | 0.930 |
Why?
| | Sodium Potassium Chloride Symporter Inhibitors | 1 | 2024 | 15 | 0.910 |
Why?
| | Shock, Cardiogenic | 1 | 2024 | 60 | 0.890 |
Why?
| | Length of Stay | 12 | 2024 | 1127 | 0.890 |
Why?
| | Hypertension | 2 | 2023 | 1242 | 0.860 |
Why?
| | Reperfusion Injury | 2 | 2022 | 272 | 0.820 |
Why?
| | Critical Care | 6 | 2024 | 553 | 0.810 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2022 | 232 | 0.790 |
Why?
| | Tissue Inhibitor of Metalloproteinase-2 | 3 | 2021 | 15 | 0.740 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 3 | 2021 | 29 | 0.740 |
Why?
| | Cardio-Renal Syndrome | 2 | 2019 | 12 | 0.730 |
Why?
| | Phenotype | 3 | 2024 | 3076 | 0.720 |
Why?
| | Cystatin C | 2 | 2021 | 65 | 0.670 |
Why?
| | Glomerular Filtration Rate | 3 | 2022 | 711 | 0.650 |
Why?
| | Respiration, Artificial | 10 | 2024 | 613 | 0.640 |
Why?
| | Fontan Procedure | 2 | 2019 | 173 | 0.630 |
Why?
| | Adolescent | 26 | 2025 | 20393 | 0.620 |
Why?
| | Aorta, Thoracic | 1 | 2021 | 262 | 0.620 |
Why?
| | Fluid Therapy | 1 | 2020 | 134 | 0.610 |
Why?
| | Intensive Care Units | 9 | 2024 | 738 | 0.610 |
Why?
| | Esthetics | 1 | 2018 | 49 | 0.610 |
Why?
| | Cicatrix | 1 | 2018 | 59 | 0.590 |
Why?
| | Publications | 1 | 2018 | 41 | 0.580 |
Why?
| | Pacemaker, Artificial | 1 | 2018 | 110 | 0.560 |
Why?
| | Renal Insufficiency | 1 | 2019 | 149 | 0.540 |
Why?
| | Vasodilator Agents | 2 | 2016 | 326 | 0.540 |
Why?
| | Postoperative Care | 1 | 2018 | 241 | 0.540 |
Why?
| | Reoperation | 1 | 2019 | 545 | 0.530 |
Why?
| | Jugular Veins | 2 | 2019 | 40 | 0.530 |
Why?
| | Consensus | 6 | 2025 | 616 | 0.510 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2016 | 48 | 0.500 |
Why?
| | Registries | 8 | 2024 | 1896 | 0.490 |
Why?
| | Defibrillators, Implantable | 1 | 2018 | 300 | 0.480 |
Why?
| | Brain | 3 | 2024 | 2679 | 0.460 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 913 | 0.460 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2014 | 29 | 0.450 |
Why?
| | Hepatitis A Virus Cellular Receptor 1 | 3 | 2024 | 42 | 0.420 |
Why?
| | Diuretics | 3 | 2024 | 76 | 0.420 |
Why?
| | Treatment Outcome | 15 | 2024 | 10230 | 0.410 |
Why?
| | Pulmonary Valve Stenosis | 1 | 2013 | 19 | 0.410 |
Why?
| | Young Adult | 17 | 2025 | 12426 | 0.400 |
Why?
| | Heparin | 1 | 2014 | 253 | 0.400 |
Why?
| | Renal Dialysis | 4 | 2024 | 423 | 0.400 |
Why?
| | Lipocalins | 2 | 2024 | 36 | 0.390 |
Why?
| | Erythropoietin | 2 | 2023 | 86 | 0.390 |
Why?
| | Venous Thrombosis | 1 | 2014 | 176 | 0.390 |
Why?
| | Magnetic Resonance Imaging | 1 | 2024 | 3408 | 0.380 |
Why?
| | Hypothermia, Induced | 2 | 2024 | 76 | 0.380 |
Why?
| | Anticoagulants | 3 | 2023 | 637 | 0.370 |
Why?
| | Pulmonary Valve Insufficiency | 1 | 2012 | 40 | 0.370 |
Why?
| | Quality of Life | 2 | 2023 | 2704 | 0.360 |
Why?
| | Cohort Studies | 9 | 2024 | 5420 | 0.360 |
Why?
| | Body Surface Potential Mapping | 1 | 2010 | 8 | 0.360 |
Why?
| | Aspirin | 1 | 2014 | 380 | 0.350 |
Why?
| | Tachycardia, Atrioventricular Nodal Reentry | 1 | 2010 | 30 | 0.350 |
Why?
| | Incidence | 4 | 2022 | 2644 | 0.340 |
Why?
| | Intensive Care Units, Neonatal | 5 | 2024 | 226 | 0.340 |
Why?
| | Renal Insufficiency, Chronic | 3 | 2025 | 566 | 0.330 |
Why?
| | Tachycardia, Supraventricular | 1 | 2009 | 44 | 0.320 |
Why?
| | Models, Biological | 2 | 2019 | 1722 | 0.320 |
Why?
| | Severity of Illness Index | 6 | 2024 | 2742 | 0.320 |
Why?
| | Heart Conduction System | 1 | 2009 | 95 | 0.320 |
Why?
| | Systemic Inflammatory Response Syndrome | 4 | 2022 | 85 | 0.310 |
Why?
| | Cryosurgery | 1 | 2009 | 57 | 0.310 |
Why?
| | Cardiotonic Agents | 2 | 2021 | 126 | 0.310 |
Why?
| | Heart | 3 | 2022 | 637 | 0.300 |
Why?
| | Delphi Technique | 3 | 2024 | 225 | 0.300 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2023 | 378 | 0.290 |
Why?
| | Time Factors | 8 | 2022 | 6556 | 0.280 |
Why?
| | Prognosis | 5 | 2024 | 3794 | 0.280 |
Why?
| | Ischemia | 2 | 2022 | 406 | 0.280 |
Why?
| | Child, Hospitalized | 3 | 2022 | 49 | 0.270 |
Why?
| | Catheter Ablation | 1 | 2010 | 335 | 0.270 |
Why?
| | Survival Rate | 4 | 2024 | 1877 | 0.270 |
Why?
| | Pulmonary Artery | 1 | 2013 | 1096 | 0.270 |
Why?
| | Age Factors | 6 | 2022 | 3144 | 0.260 |
Why?
| | Vasoconstrictor Agents | 2 | 2024 | 127 | 0.260 |
Why?
| | Heart Transplantation | 2 | 2022 | 721 | 0.260 |
Why?
| | Quality Improvement | 3 | 2024 | 1103 | 0.250 |
Why?
| | Logistic Models | 5 | 2024 | 1988 | 0.250 |
Why?
| | Postoperative Period | 3 | 2024 | 329 | 0.240 |
Why?
| | Interleukin-18 | 2 | 2024 | 237 | 0.240 |
Why?
| | Risk Assessment | 6 | 2024 | 3240 | 0.230 |
Why?
| | Bumetanide | 1 | 2024 | 4 | 0.230 |
Why?
| | Comorbidity | 5 | 2022 | 1547 | 0.230 |
Why?
| | Renin | 1 | 2024 | 32 | 0.230 |
Why?
| | Addison Disease | 1 | 2024 | 43 | 0.230 |
Why?
| | Acute Disease | 5 | 2023 | 980 | 0.220 |
Why?
| | Adrenal Insufficiency | 1 | 2024 | 32 | 0.220 |
Why?
| | Vasopressins | 1 | 2024 | 64 | 0.220 |
Why?
| | Global Health | 2 | 2024 | 329 | 0.220 |
Why?
| | Consent Forms | 1 | 2023 | 12 | 0.220 |
Why?
| | Infant, Premature | 4 | 2024 | 541 | 0.220 |
Why?
| | Cardiac Output, Low | 2 | 2021 | 66 | 0.210 |
Why?
| | Multiple Organ Failure | 1 | 2024 | 122 | 0.210 |
Why?
| | Health Information Systems | 1 | 2022 | 18 | 0.200 |
Why?
| | Odds Ratio | 3 | 2022 | 1023 | 0.200 |
Why?
| | Informed Consent | 1 | 2023 | 170 | 0.200 |
Why?
| | Hydrocortisone | 1 | 2024 | 307 | 0.200 |
Why?
| | Forecasting | 1 | 2024 | 359 | 0.190 |
Why?
| | Hypernatremia | 1 | 2021 | 9 | 0.190 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 110 | 0.190 |
Why?
| | Nephrology | 1 | 2022 | 60 | 0.190 |
Why?
| | Sodium | 1 | 2022 | 206 | 0.190 |
Why?
| | Surveys and Questionnaires | 5 | 2024 | 5406 | 0.190 |
Why?
| | Mice, Inbred C57BL | 2 | 2022 | 5440 | 0.190 |
Why?
| | Benzodiazepines | 1 | 2022 | 136 | 0.180 |
Why?
| | Hyponatremia | 1 | 2021 | 40 | 0.180 |
Why?
| | Predictive Value of Tests | 2 | 2024 | 1952 | 0.180 |
Why?
| | Survival Analysis | 3 | 2020 | 1274 | 0.180 |
Why?
| | Coinfection | 1 | 2022 | 131 | 0.180 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2022 | 209 | 0.180 |
Why?
| | Perfusion | 1 | 2021 | 197 | 0.170 |
Why?
| | Adenosine Monophosphate | 1 | 2021 | 63 | 0.170 |
Why?
| | Catheters, Indwelling | 1 | 2020 | 80 | 0.170 |
Why?
| | Multivariate Analysis | 1 | 2024 | 1502 | 0.170 |
Why?
| | Bicarbonates | 1 | 2020 | 42 | 0.170 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2022 | 253 | 0.170 |
Why?
| | Metabolic Clearance Rate | 2 | 2019 | 118 | 0.160 |
Why?
| | Machine Learning | 1 | 2024 | 443 | 0.160 |
Why?
| | Phosphodiesterase 3 Inhibitors | 1 | 2019 | 14 | 0.160 |
Why?
| | Bioprosthesis | 1 | 2019 | 40 | 0.150 |
Why?
| | Heart Failure, Diastolic | 1 | 2019 | 21 | 0.150 |
Why?
| | Adult | 11 | 2024 | 35576 | 0.150 |
Why?
| | Guideline Adherence | 1 | 2023 | 526 | 0.150 |
Why?
| | Asphyxia Neonatorum | 1 | 2018 | 18 | 0.150 |
Why?
| | Kinetics | 2 | 2024 | 1642 | 0.150 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2021 | 203 | 0.150 |
Why?
| | Kidney Function Tests | 1 | 2019 | 152 | 0.150 |
Why?
| | Recurrence | 2 | 2019 | 1007 | 0.150 |
Why?
| | Echocardiography | 3 | 2019 | 629 | 0.150 |
Why?
| | Propensity Score | 1 | 2019 | 265 | 0.140 |
Why?
| | Thrombocytopenia | 1 | 2019 | 186 | 0.140 |
Why?
| | Inpatients | 1 | 2022 | 467 | 0.140 |
Why?
| | Neonatologists | 1 | 2017 | 6 | 0.140 |
Why?
| | Heart Valve Prosthesis | 1 | 2019 | 112 | 0.140 |
Why?
| | Pulmonary Valve | 1 | 2019 | 93 | 0.140 |
Why?
| | Nephrologists | 1 | 2017 | 12 | 0.140 |
Why?
| | Heart Valve Diseases | 1 | 2019 | 152 | 0.140 |
Why?
| | Early Medical Intervention | 1 | 2018 | 57 | 0.140 |
Why?
| | Fibroblast Growth Factors | 1 | 2018 | 170 | 0.140 |
Why?
| | Brain Diseases | 1 | 2018 | 137 | 0.140 |
Why?
| | Chi-Square Distribution | 2 | 2021 | 516 | 0.140 |
Why?
| | Gestational Age | 5 | 2022 | 874 | 0.140 |
Why?
| | ROC Curve | 3 | 2024 | 503 | 0.130 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2019 | 177 | 0.130 |
Why?
| | Pilot Projects | 2 | 2021 | 1587 | 0.130 |
Why?
| | Cell Cycle Checkpoints | 1 | 2017 | 95 | 0.130 |
Why?
| | Early Diagnosis | 1 | 2018 | 234 | 0.130 |
Why?
| | Research Design | 1 | 2022 | 1044 | 0.130 |
Why?
| | Pain | 1 | 2022 | 789 | 0.130 |
Why?
| | Thoracic Surgery | 1 | 2018 | 122 | 0.130 |
Why?
| | Immunocompromised Host | 1 | 2018 | 198 | 0.130 |
Why?
| | Hemodynamics | 1 | 2021 | 1090 | 0.130 |
Why?
| | Hospitalization | 3 | 2021 | 2070 | 0.120 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2019 | 2012 | 0.120 |
Why?
| | Algorithms | 1 | 2022 | 1622 | 0.120 |
Why?
| | United States | 6 | 2023 | 13903 | 0.120 |
Why?
| | Cross-Sectional Studies | 3 | 2022 | 5066 | 0.110 |
Why?
| | Cattle | 2 | 2019 | 977 | 0.110 |
Why?
| | Pediatric Obesity | 1 | 2021 | 572 | 0.110 |
Why?
| | Tachycardia | 1 | 2014 | 57 | 0.110 |
Why?
| | Bayes Theorem | 1 | 2015 | 375 | 0.110 |
Why?
| | Follow-Up Studies | 3 | 2019 | 4897 | 0.110 |
Why?
| | Blalock-Taussig Procedure | 1 | 2013 | 4 | 0.100 |
Why?
| | Feasibility Studies | 1 | 2017 | 868 | 0.100 |
Why?
| | Birth Weight | 3 | 2023 | 505 | 0.100 |
Why?
| | Aminoglycosides | 2 | 2023 | 23 | 0.100 |
Why?
| | Fetal Growth Retardation | 1 | 2018 | 550 | 0.100 |
Why?
| | Mice | 4 | 2022 | 16937 | 0.100 |
Why?
| | Animals | 6 | 2022 | 35362 | 0.100 |
Why?
| | Oxidative Stress | 1 | 2019 | 1269 | 0.100 |
Why?
| | Catheterization | 1 | 2013 | 175 | 0.100 |
Why?
| | Ventricular Function, Right | 1 | 2014 | 276 | 0.090 |
Why?
| | Organ Size | 1 | 2012 | 447 | 0.090 |
Why?
| | Coronary Angiography | 1 | 2013 | 306 | 0.090 |
Why?
| | Colorado | 2 | 2018 | 4421 | 0.090 |
Why?
| | Pulmonary Embolism | 1 | 2012 | 211 | 0.080 |
Why?
| | Fluoroscopy | 1 | 2010 | 156 | 0.080 |
Why?
| | Age Distribution | 2 | 2022 | 372 | 0.080 |
Why?
| | Professional Competence | 1 | 2010 | 94 | 0.080 |
Why?
| | Acute-Phase Proteins | 2 | 2019 | 67 | 0.080 |
Why?
| | Aging | 1 | 2019 | 1776 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2017 | 1279 | 0.080 |
Why?
| | Aged | 3 | 2022 | 22103 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 1 | 2017 | 1266 | 0.080 |
Why?
| | Neoplasms | 1 | 2022 | 2470 | 0.070 |
Why?
| | India | 2 | 2018 | 170 | 0.070 |
Why?
| | Canada | 2 | 2019 | 350 | 0.070 |
Why?
| | Hospitals, Pediatric | 2 | 2020 | 509 | 0.060 |
Why?
| | Databases, Factual | 2 | 2022 | 1269 | 0.060 |
Why?
| | Organ Dysfunction Scores | 1 | 2024 | 44 | 0.060 |
Why?
| | Neuroprotection | 1 | 2023 | 38 | 0.050 |
Why?
| | Parenteral Nutrition, Total | 1 | 2022 | 26 | 0.050 |
Why?
| | Potassium | 1 | 2022 | 143 | 0.050 |
Why?
| | Vancomycin | 1 | 2022 | 78 | 0.050 |
Why?
| | Michigan | 1 | 2021 | 104 | 0.050 |
Why?
| | Prostaglandins | 1 | 2021 | 93 | 0.050 |
Why?
| | Educational Status | 1 | 2023 | 470 | 0.050 |
Why?
| | Confidence Intervals | 1 | 2022 | 317 | 0.050 |
Why?
| | Blood Coagulation | 1 | 2023 | 238 | 0.040 |
Why?
| | Societies, Medical | 1 | 2024 | 751 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2012 | 2004 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2022 | 4063 | 0.040 |
Why?
| | Fluid Shifts | 1 | 2019 | 2 | 0.040 |
Why?
| | Graft Survival | 1 | 2022 | 512 | 0.040 |
Why?
| | Matched-Pair Analysis | 1 | 2019 | 40 | 0.040 |
Why?
| | Goals | 1 | 2021 | 160 | 0.040 |
Why?
| | Tertiary Care Centers | 1 | 2020 | 151 | 0.040 |
Why?
| | Monte Carlo Method | 1 | 2019 | 143 | 0.040 |
Why?
| | Sex Distribution | 1 | 2019 | 359 | 0.040 |
Why?
| | Term Birth | 1 | 2018 | 20 | 0.040 |
Why?
| | Urodynamics | 1 | 2019 | 35 | 0.040 |
Why?
| | Hepatocytes | 1 | 2019 | 216 | 0.040 |
Why?
| | Substance Abuse, Intravenous | 1 | 2019 | 108 | 0.040 |
Why?
| | Homeostasis | 1 | 2022 | 611 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2018 | 110 | 0.040 |
Why?
| | RNA, Viral | 1 | 2021 | 619 | 0.040 |
Why?
| | Dialysis | 1 | 2017 | 18 | 0.040 |
Why?
| | North America | 1 | 2018 | 291 | 0.040 |
Why?
| | History, 20th Century | 1 | 2019 | 291 | 0.040 |
Why?
| | New Zealand | 1 | 2017 | 45 | 0.030 |
Why?
| | Pregnancy | 2 | 2021 | 6402 | 0.030 |
Why?
| | Prosthesis Design | 1 | 2019 | 306 | 0.030 |
Why?
| | Australia | 1 | 2017 | 243 | 0.030 |
Why?
| | Sex Factors | 1 | 2022 | 1968 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2019 | 720 | 0.030 |
Why?
| | Metabolome | 1 | 2019 | 338 | 0.030 |
Why?
| | Middle Aged | 3 | 2022 | 31154 | 0.030 |
Why?
| | Body Weight | 1 | 2019 | 940 | 0.030 |
Why?
| | Weight Gain | 1 | 2018 | 510 | 0.030 |
Why?
| | Premature Birth | 1 | 2018 | 314 | 0.030 |
Why?
| | Blood Pressure | 1 | 2022 | 1736 | 0.030 |
Why?
| | Myocardium | 1 | 2019 | 980 | 0.030 |
Why?
| | Metabolomics | 1 | 2019 | 652 | 0.030 |
Why?
| | Patient Discharge | 1 | 2020 | 857 | 0.030 |
Why?
| | Body Mass Index | 1 | 2022 | 2273 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2019 | 874 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2023 | 1717 | 0.030 |
Why?
| | Smoking | 1 | 2019 | 1501 | 0.020 |
Why?
| | Infant, Low Birth Weight | 1 | 1993 | 135 | 0.020 |
Why?
| | Pulmonary Surfactants | 1 | 1993 | 106 | 0.020 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 1993 | 103 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3381 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2019 | 1001 | 0.020 |
Why?
| | Stroke | 1 | 2019 | 1071 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2022 | 7086 | 0.020 |
Why?
| | Diagnostic Imaging | 1 | 2012 | 334 | 0.020 |
Why?
| | Electrocardiography | 1 | 2012 | 608 | 0.020 |
Why?
| | Lung | 1 | 1993 | 3930 | 0.010 |
Why?
| | Fetal Organ Maturity | 1 | 1993 | 27 | 0.010 |
Why?
| | Placebos | 1 | 1993 | 201 | 0.010 |
Why?
| | Cerebral Hemorrhage | 1 | 1993 | 107 | 0.010 |
Why?
| | Retinopathy of Prematurity | 1 | 1993 | 141 | 0.010 |
Why?
| | Cerebral Palsy | 1 | 1993 | 96 | 0.010 |
Why?
| | Intubation, Intratracheal | 1 | 1993 | 239 | 0.010 |
Why?
| | Psychomotor Performance | 1 | 1993 | 313 | 0.010 |
Why?
| | Lung Diseases | 1 | 1993 | 742 | 0.000 |
Why?
|
|
Gist's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|